IGF-LR3 1mg – Research-Grade Peptide

IGF-LR3 (Insulin-like Growth Factor – Long Revised) is a research-grade peptide that represents an advanced form of IGF-I, optimized for enhanced bioavailability and reduced immunogenicity. This peptide retains the key growth-promoting properties associated with IGF-I while offering improved stability and potential for diverse applications in biological studies.

Research Context

Igf-LR3 is derived from human Insulin-like Growth Factor 1 (IGF-1) by modifying its structure to improve its therapeutic and research utility. The modifications include the removal of a serine residue at position 67, which helps in reducing immunogenicity, making it particularly useful for extended periods of administration without adverse immune responses.

Research Overview

This peptide has been extensively studied for its role in cell proliferation, differentiation, and tissue regeneration. It is often utilized in studies related to oncology, endocrinology, and developmental biology due to its potent growth-promoting effects on various cell types.

Key Research Focus Areas

• In vitro cell culture experiments: IGF-LR3 enhances cell proliferation and differentiation in various cell lines, making it a valuable tool for studying cellular mechanisms.
• Tissue regeneration studies: Its ability to promote tissue growth makes IGF-LR3 relevant for research on wound healing, organ regeneration, and stem cell biology.
• Oncology investigations: Research into the role of IGF-LR3 in cancer development and progression can provide insights into potential therapeutic targets or diagnostic markers.

Compliance Statement

For research use only. Not for human or animal consumption. This product is intended for use in experimental settings where its properties are to be evaluated under controlled conditions by trained professionals familiar with the associated risks and safety protocols.